Cubist Systematic Strategies, LLC - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 158 filers reported holding ZIOPHARM ONCOLOGY INC in Q2 2021. The put-call ratio across all filers is 0.91 and the average weighting 0.0%.

Quarter-by-quarter ownership
Cubist Systematic Strategies, LLC ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q2 2023$21,041
-96.5%
41,257
-88.2%
0.00%
-100.0%
Q3 2022$602,000
+6588.9%
349,867
+4589.3%
0.00%
Q2 2022$9,000
-69.0%
7,461
-82.9%
0.00%
Q1 2022$29,000
-82.6%
43,707
-71.5%
0.00%
-100.0%
Q4 2021$167,000
+595.8%
153,618
+1072.0%
0.00%
Q3 2021$24,000
-73.9%
13,107
-62.4%
0.00%
-100.0%
Q2 2021$92,000
-47.1%
34,835
-28.0%
0.00%
-50.0%
Q1 2021$174,000
+39.2%
48,394
-2.4%
0.00%0.0%
Q4 2020$125,000
-27.7%
49,575
-28.0%
0.00%
-33.3%
Q3 2020$173,000
+408.8%
68,817
+568.1%
0.00%
+200.0%
Q2 2020$34,000
-76.9%
10,300
-82.9%
0.00%
-75.0%
Q1 2020$147,000
-73.9%
60,161
-37.8%
0.00%
-60.0%
Q2 2019$564,000
+652.0%
96,717
+715.2%
0.01%
+100.0%
Q1 2017$75,000
-34.2%
11,864
-43.1%
0.01%
-28.6%
Q2 2016$114,000
+225.7%
20,850
+619.2%
0.01%
+250.0%
Q2 2015$35,000
-76.5%
2,899
-79.1%
0.00%
-71.4%
Q1 2015$149,00013,8640.01%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q2 2021
NameSharesValueWeighting ↓
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 14,013,093$9,142,0000.78%
MSD Partners, L.P. 15,151,516$9,885,0000.54%
MSD Partners, L.P. 7,575,758$4,942,0000.27%
CHIRON CAPITAL MANAGEMENT, LLC 144,960$95,0000.06%
MAGNOLIA CAPITAL ADVISORS LLC 185,456$121,0000.05%
Allred Capital Management, LLC 128,000$83,0000.04%
Virtus ETF Advisers LLC 131,413$86,0000.04%
GSA CAPITAL PARTNERS LLP 232,438$152,0000.02%
ACT WEALTH MANAGEMENT, LLC 37,071$24,0000.01%
Pathway Financial Advisors LLC 30,000$20,0000.01%
View complete list of ZIOPHARM ONCOLOGY INC shareholders